Alpha-synuclein induced immune response triggers Parkinson’s diseaseRebekah G Parkinson, Tony Xu, Zizheng Xian et al.
Targeting the T-cell response as a novel therapeutic strategy for Parkinson's diseaseFederica Maria Conedera, Hans Rudolf Widmer, Volker Enzmann, Jens Volker Stein